Young women with breast cancer often have fertility concerns

This article originally appeared here.
Share this content:
Fertility Concerns Common for Young Women With Breast CA
Fertility Concerns Common for Young Women With Breast CA

(HealthDay News) -- Fertility concerns are common among young women with newly diagnosed breast cancer, although only a minority pursue fertility preservation strategies, according to a study published online Feb. 24 in the Journal of Clinical Oncology.

Kathryn J. Ruddy, M.D., M.P.H., from the Dana-Farber Cancer Institute in Boston, and colleagues surveyed women (≤40 years) with newly diagnosed early-stage breast cancer regarding fertility concerns. Sociodemographic, medical, and treatment data were investigated in a baseline survey, while a modified Fertility Issues Survey was used to examine fertility concern and preservation items.

The researchers found that 68 percent of the 620 eligible respondents (median age, 37 years) discussed fertility issues with their physicians before therapy initiation. Fifty-one percent of women expressed concern about becoming infertile after treatment. Due to fertility concerns, 1 percent of women chose not to receive chemotherapy and 2 percent selected one chemotherapy regimen over another. Similarly, 1 percent of women considered not receiving endocrine therapy; 3 percent opted not to receive endocrine therapy; and 11 percent considered receiving endocrine therapy for less than five years due to concerns about fertility. Fertility preservation strategies were used by 10 percent of women. Younger age, nonwhite race, not having children, and receipt of chemotherapy correlated with greater concern about fertility.

"Many young women with newly diagnosed breast cancer have concerns about fertility, and for some, these substantially affect their treatment decisions," the authors write.

Full Text (subscription or payment may be required)

You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs